Cara Therapeutics, Inc. (CARA) financial statements (2022 and earlier)

Company profile

Business Address 4 STAMFORD PLAZA
STAMFORD, CT 06902
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:236,789251,490218,165182,77992,56958,276106,740
Cash and cash equivalents13,45331,68318,30515,0819,38812,09215,101
Short-term investments153,582149,242136,701146,30283,18146,18491,640
Other undisclosed cash, cash equivalents, and short-term investments69,75470,56563,15921,396  (1)
Restricted cash and investments   361 700 
Receivables1,1522,0641,7871,590731852384
Inventory, net of allowances, customer advances and progress billings2,584      
Inventory2,584      
Prepaid expense2,51912,0768,8634,8051,6351,5301,729
Other undisclosed current assets(69,754)(70,565)(63,159)(21,396)1238781
Total current assets:173,290195,065165,656168,13995,05861,445108,934
Noncurrent Assets
Operating lease, right-of-use asset2,9734,2793,036
Property, plant and equipment6318407008801,1771,6141,263
Long-term investments and receivables69,75470,56563,15921,396   
Long-term investments69,75470,56563,15921,396   
Restricted cash and investments408408408408769769700
Total noncurrent assets:73,76676,09267,30322,6841,9462,3831,963
TOTAL ASSETS:247,056271,157232,959190,82397,00463,828110,897
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:15,86116,88119,66513,6228,50611,5335,268
Accounts payable5,6254,8939,1004,3713,8294,7381,965
Accrued liabilities629839635802457929557
Employee-related liabilities4,9594,9553,2932,3701,8641,5141,204
Other undisclosed accounts payable and accrued liabilities4,6486,1946,6376,0792,3564,3521,542
Deferred revenue  22,262
Debt  967    
Contract with customer, liability26,825
Other undisclosed current liabilities1,7551,602     
Total current liabilities:17,61618,48342,89440,4478,50611,5335,268
Noncurrent Liabilities
Long-term debt and lease obligation1,9183,6733,352    
Operating lease, liability1,9183,6733,352
Liabilities, other than long-term debt   16,7461,7181,570585
Deferred revenue and credits1,7181,570585
Contract with customer, liability15,184
Deferred rent credit   1,562
Total noncurrent liabilities:3,8367,3463,35216,7461,7181,570585
Total liabilities:21,45225,82946,24657,19310,22413,1035,853
Stockholders' equity
Stockholders' equity attributable to parent227,522249,001186,713133,63086,78050,725105,044
Common stock53504739332727
Additional paid in capital708,585641,195587,223428,059307,158212,866209,943
Accumulated other comprehensive income (loss)(358)73170(114)(70)3(35)
Accumulated deficit(480,758)(392,317)(400,727)(294,354)(220,341)(162,171)(104,891)
Total stockholders' equity:227,522249,001186,713133,63086,78050,725105,044
Other undisclosed liabilities and equity(1,918)(3,673)     
TOTAL LIABILITIES AND EQUITY:247,056271,157232,959190,82397,00463,828110,897

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues23,028135,08219,88613,469911863,803
Gross profit:23,028135,08219,88613,469911863,803
Operating expenses(112,111)(129,697)(131,565)(90,851)(60,396)(58,486)(28,991)
Operating income (loss):(89,083)5,385(111,679)(77,382)(59,485)(58,400)(25,188)
Nonoperating income
(Other Nonoperating income)
6422,3344,4902,9801,156652101
Income (loss) from continuing operations before income taxes:(88,441)7,719(107,189)(74,402)(58,329)(57,748)(25,087)
Income tax benefit 691816389204468397
Net income (loss) available to common stockholders, diluted:(88,441)8,410(106,373)(74,013)(58,125)(57,280)(24,690)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(88,441)8,410(106,373)(74,013)(58,125)(57,280)(24,690)
Other comprehensive income (loss)(431)(97)284(44)(73)38(35)
Comprehensive income (loss), net of tax, attributable to parent:(88,872)8,313(106,089)(74,057)(58,198)(57,242)(24,725)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: